5:24 PM
 | 
Jun 24, 2014
 |  BC Extra  |  Financial News

Actinium, Heron planning follow-ons

Late Tuesday, Actinium Pharmaceuticals Inc. (NYSE-M:ATNM) and Heron Therapeutics Inc. (NASDAQ:HRTX) proposed follow-ons, but neither company disclosed how many shares they plan to issue or how much they expect to raise. Actinium's follow-on is underwritten by Canaccord Genuity and Laidlaw, while Heron's offering is...

Read the full 206 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >